Jing Xu

20030109432, Jun 12, 2003

Dec 10, 2001

09/940180

William Zuo - Sugar Land TX, US
Dongfang Yu - Houston TX, US
David Yang - Sugar Land TX, US
Jing Ya Xu - Missouri City TX, US

A61K038/16
C07K014/00

514/012000, 530/350000, 530/410000, 530/409000

Novel drug complexes comprising a polypeptide carrier moiety comprising glutamic acid and at least one of the group consisting of aspartic acid, alanine, asparagine, glutamine, glycine, and any combinations thereof, are disclosed. The drug moiety is a therapeutic metal selected from the group consisting of platinum, iron, gadolinium, rhenium, manganese, cobalt, indium, gallium or rhodium. Methods for making said complexes, compositions comprising said complexes, methods for making saiduch compositions, and methods for treating a patient comprising use of said complexes and/or compositions are further disclosed.

20110262517, Oct 27, 2011

Apr 7, 2008

12/594777

Jun O. Liu - Clarksville MD, US
Curtis R. Chong - Honolulu HI, US
Jing Xu - Parkville MD, US
Jun Lu - Monmouth Junction NJ, US
Shridhar Bhat - Cockeysville MD, US

THE JOHNS HOPKINS UNIVERSITY - Baltimore MD

A61K 9/00
A61K 31/496
A61P 35/00
A61K 39/395
A61P 27/02
C12Q 1/26
A61K 31/4178

424423, 435 25, 51425407, 514397, 424427, 544366, 4241331

Described herein are methods of inhibiting angiogenesis, and treating or preventing a disease or disorder (or symptoms thereof) associated with angiogenesis, wherein an anti-angiogenesis compound is administered to a subject.

20130102614, Apr 25, 2013

Apr 11, 2012

13/444642

Jun O. Liu - Clarkesvill MD, US
Curtis R. Chong - Honolulu HI, US
Jing Xu - Parkville MD, US
Juu Lu - Monmouth NJ, US
Shridhar Bhat - Cockeysville MD, US

A61K 31/496

51425407, 544366, 5483111

Described herein are methods of inhibiting angiogenesis, and treating and preventing disorders associated with angiogenesis by administering anti-angiogenesis compounds to a subject.

20210331582, Oct 28, 2021

Jul 7, 2021

17/369085

- Dublin, IE
Tamara Orshanskaya - Farmington Hills MI, US
Jing Xu - Ann Arbor MI, US

Eaton Intelligent Power Limited - Dublin

B60K 15/035
F16K 1/30
F16K 24/04
B60K 15/03

A fill limit vent valve for a fuel system includes a housing assembly, an outlet port and a flow dam. The housing assembly has a main housing including a cylindrical body and an upper housing portion. The upper housing portion has a lower wall that defines an orifice and an outer cylindrical wall that defines an upper housing chamber. The outlet port is formed on the main housing and fluidly communicates fuel vapor out of the fill limit valve. The orifice is offset from a centerpoint of the lower wall in a direction away from the outlet port. The flow dam extends from the lower wall into the upper housing chamber and connects on opposite ends to the outer cylindrical wall. The flow dam and upper housing chamber cooperating to form a liquid trap that mitigates the possibility of liquid fuel from reaching the outlet port from the orifice.

20190255938, Aug 22, 2019

May 2, 2019

16/401222

- Dublin, IE
Tamara Orshanskaya - Farmington Hills MI, US
Jing Xu - Ann Arbor MI, US

Eaton Intelligent Power Limited - Dublin

B60K 15/035
F16K 24/04
F16K 1/30

A fill limit vent valve for a fuel system includes a housing assembly, an outlet port and a flow dam. The housing assembly has a main housing including a cylindrical body and an upper housing portion. The upper housing portion has a lower wall that defines an orifice and an outer cylindrical wall that defines an upper housing chamber. The outlet port is formed on the main housing and fluidly communicates fuel vapor out of the fill limit valve. The orifice is offset from a centerpoint of the lower wall in a direction away from the outlet port. The flow dam extends from the lower wall into the upper housing chamber and connects on opposite ends to the outer cylindrical wall. The flow dam and upper housing chamber cooperating to form a liquid trap that mitigates the possibility of liquid fuel from reaching the outlet port from the orifice.